Cardiovascular Risk Reduction

Best of Preventive Cardiology Summit: Applying New Options for Optimal CV Risk Management

Best of Preventive Cardiology Summit: Applying New Options for Optimal CV Risk Management

In the United States, cardiovascular disease (CVD) is the leading cause of…

Expiration Date: 1/20/2021

Max Credits: 0

View Activity

Cardiovascular Risk Reduction With PCSK9 Inhibitors: Evolving Evidence, Recommendations, and Controversies

Cardiovascular Risk Reduction With PCSK9 Inhibitors: Evolving Evidence, Recommendations, and Controversies

Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have prov…

Expiration Date: 7/15/2020

Max Credits: 0

View Activity

Test Your Knowledge in the Use of PCSK9 Inhibitors in the Reduction of CV Risk: A Wheel of Knowledge Challenge

Test Your Knowledge in the Use of PCSK9 Inhibitors in the Reduction of CV Risk: A Wheel of Knowledge Challenge

As clinical data emerge regarding the benefit of proprotein convertase sub…

Expiration Date: 1/9/2020

Max Credits: 0

View Activity

Advancing Science in Residual Cardiovascular Risk: Will New Cardiovascular Outcomes Trials Bring a Paradigm Shift in Patient Care?

Advancing Science in Residual Cardiovascular Risk: Will New Cardiovascular Outcomes Trials Bring a Paradigm Shift in Patient Care?

Despite therapeutic advances, cardiovascular disease (CVD) continues to be…

Expiration Date: 1/3/2020

Max Credits: 0

View Activity

PCSK9 Inhibitors in Prevention: How to Use Them Like the Experts

PCSK9 Inhibitors in Prevention: How to Use Them Like the Experts

As clinical data emerge regarding the benefit of proprotein convertase sub…

Expiration Date: 8/30/2019

Max Credits: 0

View Activity

Best of Lipid Forum® 2017 — Beyond Statin Therapy: Getting the Low Down on LDL Management

Best of Lipid Forum® 2017 — Beyond Statin Therapy: Getting the Low Down on LDL Management

Nearly one-third of adults in the United States have an elevated low-densi…

Expiration Date: 3/8/2019

Max Credits: 0

View Activity

Back to the Future: Clinical Experience with and Access to Lipid-Lowering Agents of the Past, Present, and Future

Back to the Future: Clinical Experience with and Access to Lipid-Lowering Agents of the Past, Present, and Future

With each passing year we gain new insight and understanding around the cl…

Expiration Date: 8/11/2018

Max Credits: 0

View Activity

Reducing Risk Through Non-LDL-C Avenues

Reducing Risk Through Non-LDL-C Avenues

While statins are the treatment of choice for lowering LDL-C, many patient…

Expiration Date: 11/27/2018

Max Credits: 0

View Activity

Treating Dyslipidemia in Patients with Type 2 Diabetes

Treating Dyslipidemia in Patients with Type 2 Diabetes

Dyslipidemia is a key risk factor for cardiovascular disease in diabetes. …

Expiration Date: 11/27/2017

Max Credits: 0

View Activity

Treating Patients on Maximum Tolerated Dose of Statins

Treating Patients on Maximum Tolerated Dose of Statins

Managing residual risk in patients on maximally tolerated statin therapy c…

Expiration Date: 11/22/2017

Max Credits: 0

View Activity